Ribbon Bio defines new standards for molecular biology by applying innovative methods for DNA synthesis.
Ribbon Bio has raised $20.2M in total funding. The most recent round was Series A. The last funding was announced in January 2022.
Ribbon Bio's investors include Hadean Ventures, XISTA Science Ventures, tecnet equity, Lansdowne Partners, Helicase Venture.
Ribbon Bio is headquartered in Vienna, Austria.
Ribbon Bio defines new standards for molecular biology by applying innovative methods for DNA synthesis.
Ribbon Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ribbon Bio — Funding & Investors." VCBacked, January 31, 2022, https://www.vcbacked.co/company/ribbon-bio. Accessed August 14, 2026.
VCBacked. (2022). Ribbon Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ribbon-bio
{{cite web |title=Ribbon Bio — Funding & Investors |url=https://www.vcbacked.co/company/ribbon-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated